stroke
TargED Bio raises €39m for new clot-busting drug
Phil Taylor
acquired thrombotic thrombocytopenic purpura, cardiovascular, rare disease, stroke, TargED Biopharmaceuticals, thrombolysis
0 Comment
MindMaze raises $105m to seek out new neurological DTx
Phil Taylor
Alzheimer's disease, digital, digital health, digital therapeutics, financing, MindMaze, neurology, Parkinson's disease, stroke
0 Comment
FDA fast tracks Bayer’s oral anticoagulant asundexian
Phil Taylor
anticoagulant, asundexian, Bayer, Bristol-Myers Squibb, cardiology, Johnson & Johnson, milvexian, stroke
0 Comment
Boehringer invests again in AI diagnosis specialist Brainomix
Phil Taylor
Boehringer Ingelheim, Brainomix, digital, digital health, fibrosis, financing, Oncology, stroke
0 Comment
UK hospital will use MindMaze game to aid stroke recovery
Phil Taylor
digital, digital health, MindMaze, MindPod, neurology, physiotherapy, stroke
0 Comment
Biogen bolsters ischaemic stroke pipeline with thrombolytic from TMS
Phil Taylor
Biogen, central nervous system, licensing, stroke, thrombolysis
0 Comment
Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis
Ipsen’s John Chaddock on making neurotoxins a priority for healthcare systems
George Underwood
BoNTs, Botox, botulinum neurotoxins, focal spasticity, Ipsen, neurology, neurotoxins, stroke
0 Comment
Chasing Brilinta payoff, AZ details THALES data in ischemic stroke
Phil Taylor
Aspirin, AstraZeneca, Brilinta, cardiovascular disease, stroke
0 Comment